1.Analysis of related factors for preschool children s safety seat use in a district of Beijing
HU Jiangong, ZHAO Yingying, HE Chao, YOU Kai,PENG Tao
Chinese Journal of School Health 2026;47(1):42-45
Objective:
To understand the allocation and use of safety seats for preschool children and explore its related factors, so as to provide a scientific reference for promoting the usage of safety seats.
Methods:
A stratified random cluster sampling method was used to select 3 143 parents of preschool children aged 3 to 6 from six kindergartens in Shunyi District, Beijing from January 3 to 10, 2022. An online questionnaire survey was conducted to collect and evaluate the equipment and use of child safety seats in different characteristics of preschool children, as well as their scores of health beliefs. Multiple factor Logistic regression analysis was used to investigated the related factors of safety seat configuration and use.
Results:
The equipping rate and usage rate of safety seats for preschool children were 66.56% and 58.45%, respectively. The proportion of equipped and used safety seats for preschool children in core families (69.52%, 62.23%) were higher than that in large families (64.35%, 55.62%), only child families ( 72.39 %, 64.87%) were higher than non only child families (61.49%, 52.86%), and urban families (71.63%, 63.04%) were higher than rural families (52.31%, 45.51%) ( χ 2=9.23, 13.86; 41.72, 46.44; 101.96 ,76.97,all P <0.05) . As the educational level of parents ( χ 2 trend =154.23,98.76) and annual income of the family ( χ 2 trend =155.78,127.69) rised, the reporting rates of the equipped and used child safety seats in the family also increased(all P <0.05 ). There were statistically significant differences in the scores of different dimensions of health beliefs for the provision ( t =-20.22-18.16) and use ( t =24.32-24.17) of safety seats for preschool children(all P <0.05). After adjusting for child sex, child age, family annual income, parental education level, family type, whether the child was an only child, and place of residence,multivariate Logistic regression analysis showed that preschool children with higher perceived susceptibility score( OR =1.11, 1.08), higher self efficacy score( OR =1.23, 1.33), and higher suggestive factors score( OR =1.08, 1.12) were more likely to have and use safety seats in their families, while preschool children with higher perceived impairments score( OR =0.82, 0.80) were less likely to have and use safety seats in their families (all P <0.05).
Conclusions
The installation rate of child safety seats needs to be improved, and there is also a certain gap in their use after installation. Parents of preschool children should improve susceptibility and self efficacy to safety seat equipment and use, and perceptual barriers should be reduced.
2.Discussion on the Treatment of Painful Diabetic Peripheral Neuropathy Based on the Theory of"Deficient-qi Induced Stagnation"from the Perspective of Collateral Disease
You PENG ; Chongsong CUI ; Yanan JING ; Yaqi ZHANG ; Yingling ZHOU ; Hang ZHANG ; Zhenjie LIU
Chinese Journal of Information on Traditional Chinese Medicine 2025;32(3):161-166
The pathogenesis of painful diabetic peripheral neuropathy(PDPN)is very complicated and tricky treat,which seriously affects the physical and mental health of patients.TCM has certain advantages in treating PDPN,but lacks theoretical guidance centered on pathogenesis.The dynamic evolution of the pathogenesis of PDPN fits the theory of"deficient-qi induced stagnation".PDPN is mainly characterized by pain,with prolonged pain entering the collaterals.This article discussed the pathogenesis of PDPN from the theory of"deficient-qi induced stagnation"based on collateral disease.Among them,the"deficient qi"is mainly responsible for the deficiency of qi,blood,yin and yang,and the collaterals are not be nourished;"stagnation"includes the pathological state of qi stagnation,phlegm and stasis caused by the abnormal movement of qi,blood and body fluid,and the obstruction of collaterals."Deficient qi"and"stagnation"interact with each other to promote the progress of PDPN.The article concluded that the key point of treatment is to regulate the deficiency qi(tonify deficiency)and remove stagnation and clear collaterals(smooth the stagnation),which could provide a new diagnosis and treatment idea and theoretical basis for the clinical differentiation and treatment of PDPN.
3.Discussion on the Treatment of Painful Diabetic Peripheral Neuropathy Based on the Theory of"Deficient-qi Induced Stagnation"from the Perspective of Collateral Disease
You PENG ; Chongsong CUI ; Yanan JING ; Yaqi ZHANG ; Yingling ZHOU ; Hang ZHANG ; Zhenjie LIU
Chinese Journal of Information on Traditional Chinese Medicine 2025;32(3):161-166
The pathogenesis of painful diabetic peripheral neuropathy(PDPN)is very complicated and tricky treat,which seriously affects the physical and mental health of patients.TCM has certain advantages in treating PDPN,but lacks theoretical guidance centered on pathogenesis.The dynamic evolution of the pathogenesis of PDPN fits the theory of"deficient-qi induced stagnation".PDPN is mainly characterized by pain,with prolonged pain entering the collaterals.This article discussed the pathogenesis of PDPN from the theory of"deficient-qi induced stagnation"based on collateral disease.Among them,the"deficient qi"is mainly responsible for the deficiency of qi,blood,yin and yang,and the collaterals are not be nourished;"stagnation"includes the pathological state of qi stagnation,phlegm and stasis caused by the abnormal movement of qi,blood and body fluid,and the obstruction of collaterals."Deficient qi"and"stagnation"interact with each other to promote the progress of PDPN.The article concluded that the key point of treatment is to regulate the deficiency qi(tonify deficiency)and remove stagnation and clear collaterals(smooth the stagnation),which could provide a new diagnosis and treatment idea and theoretical basis for the clinical differentiation and treatment of PDPN.
4.The analysis of effect of serum containing Gegen Qinlian Decoction on regulating hypoxia-induced glucose metabolism in L02 Cells and related metabolic mechanisms
Yan YOU ; Hongjing CUI ; Chengcheng PENG ; Li JIANG ; Qiyun ZHANG ; Bingtao LI ; Guoliang XU
The Journal of Practical Medicine 2025;41(7):936-943
Objective The study aimedto investigate the effects and metabolic mechanisms of Gegen Qinlian Decoction(GQD)containing serum on hypoxia-induced glucose metabolism in L02 cells.Methods The effects of five hypoxia durations(6,12,18,24,and 48 hours)on glucose consumption and cell viability of L02 cells were examined under hypoxic conditions to determine the optimal hypoxia time.Normal hepatocytes served as the normal control group.L02 cells with hypoxia-induced reduction in glucose consumption were divided into several groups:hypoxia group,metformin 2 mmol/L group,and 25 g/kg GQD groups treated with 5%,10%,and 15%GQD contain-ing serum.Glucose consumption was used as an indicator of drug efficacy.High-resolution liquid chromatography tandem quadrupole time-of-flight mass spectrometry(UPLC-Q-TOF-MS)was employed to collect metabolite signals from each group.Data were analyzed by using Progenesis QI software,and potential biomarkers were identified through online databases such as HMDB.Finally,metabolic pathways of potential biomarkers were analyzed via the Metabo Analyst 5.0 website.Results An 18 hour hypoxia period was identified as the optimal duration for the replication of the hypoxia-induced L02 cell model.GQD containing serums at 5%and 10%significantly increased glucose consumption in hypoxia-induced L02 cells after 18 hours.14 biomarkers of hypoxia-induced L02 cells were identified,with the levels of 13 biomarkers significantly increased and 1 biomarker significantly decreased.GQD containing serum notably regulated the levels of 3 biomarkers.Conclusion GQD containing serum might improve hypoxia-induced abnormal glucose metabolism in L02 cells and enhance glucose consumption by modulating glycero-phospholipid metabolism,glycosylphosphatidylinositol biosynthesis,and sphingolipid metabolism.
5.Progresses in imaging evaluation on type 1 neurofibromatosis-associated plexiform neurofibromas
Hui YOU ; Xiaoming WANG ; Yun PENG ; Biao HUANG ; Feiyun WU ; Binbin SUI ; Xiaofeng TAO ; Feng FENG
Chinese Journal of Medical Imaging Technology 2025;41(5):830-834
As the most common phenotype of type 1 neurofibromatosis(NF1),plexiform neurofibromas(pNF)exhibit early asymptomatic presentation but multisite involvement,with a risk of progression.Imaging serves as vital tool for evaluation and management of NF1-associated pNF.The progresses of imaging for evaluating NF1-related pNF were reviewed in this article.
6.Analysis of clinical factors influencing bedaquiline plasma levels and their impact on patient prognosis
Taixian YOU ; Chengjie SHU ; Minglong XU ; Mei HUANG ; Nana LI ; Zhangli PENG
The Journal of Practical Medicine 2025;41(13):2073-2081
Objective To conduct a retrospective analysis of the correlation among bedaquiline(BDQ)plasma concentrations,relevant clinical factors,and disease prognosis.Methods In this retrospective study,22 patients diagnosed with rifampicin-resistant tuberculosis(RR-TB),multidrug-resistant tuberculosis(MDR-TB),or pre-extensively drug-resistant tuberculosis(pre-XDR-TB)were enrolled.These patients were admitted to the tuberculosis ward of our hospital between February 2022 and October 2024.All patients were administered a treatment regimen containing BDQ.The cohort comprised 6 RR-TB patients(27.27%),12 MDR-TB patients(54.55%),and 4 pre-XDR-TB patients(18.18%).Peripheral blood samples were collected 2 hours after the oral administration of Bedaquiline.The plasma concentration of Bedaquiline was measured using liquid chromatography-tandem mass spectrometry(LC-MS/MS).Spearman correlation analysis was performed using R studio software with the ggplot2 and corrplot packages.The factors included the blood concentration of bedaquiline,electrocardiogram QTcF(QT interval corrected by the Fridericia method),liver and kidney function parameters,weight,age,body mass index,sex,blood uric acid level,serum creatinine level,and other relevant indicators.Results In 22 patients treated with BDQ,the plasma concentration reached a peak after 1.5 weeks of administration,and gradually stabilized after 2 weeks.The plasma concentration was approximately 1-3 μg/mL.After 24 weeks of withdrawal of bedaquiline,patients were continued to monitor their bedaquiline concentration and found that BDQ blood concentration in peripheral blood was approximate 1 μg/mL up to 36 weeks.The serum concentration of BDQ was not correlated with age,body weight,BMI,ALT,AST,GGT,TDiL,urea,uric acid and QT interval,but correlated with sputum negative transformation and serum creatinine.The correlation analysis between serum concentration of BDQ and acid-fast staining of sputum smear showed,the difference was significant(r=0.35,P<0.05).In addition,the correlation analysis between serum BDQ concentration and serum creatinine showed,the difference was significant(r=0.34,P<0.05).The results of multiple linear regression analysis showed that BDQ blood concentration was positively correlated with Scr level,and Scr was an independent factor affecting BDQ blood concentration.20 cases(90.9%,20/22)were cured,1 case died of Covid-19 virus infection,1 case was recurrence.Conclusions Regimens containing bedaquiline seem to exhibit relatively high safety profiles and good tolerability among patients with rifampicin-resistant,multidrug-resistant,or pre-extensively drug-resistant tuberculosis,typically yielding favorable treatment outcomes.The BDQ shows a positive correlation with serum creatinine(SCr).Consequently,close surveillance of BDQ levels and renal function remains of utmost importance throughout the treatment course.
7.Effects of programmed death receptor-1/programmed death receptor-ligand-1 inhibitor combined with chemotherapy on gastrointestinal function and inflammatory markers in peripheral blood of patients with advanced gastric cancer
Fang REN ; Peng QIU ; Jianglian YOU ; Qingqiang HE
Journal of Clinical Medicine in Practice 2025;29(2):14-18,23
Objective To investigate the effect of programmed death receptor-1(PD-1)/pro-grammed death receptor-ligand-1(PD-L1)inhibitor combined with chemotherapy on gastrointestinal function and inflammatory markers in peripheral blood of patients with advanced gastric cancer(AGC).Methods The clinical data of 128 AGC patients treated in our hospital from February 2022 to August 2023 were retrospectively analyzed,and they were divided into control group(64 cases re-ceived conventional chemotherapy)and study group(64 cases received PD-1/PD-L1 inhibitor treat-ment+conventional chemotherapy)according to different treatment schemes.The short-term curative effect,gastrointestinal function level and inflammatory markers in peripheral blood before and after three cycles of treatment were recorded between the two groups,and the adverse reactions of the two groups were counted.Results The objective response rate(ORR)and disease control rate(DCR)in the study group were higher than those in the control group(P<0.05).After three cycles of treatment,the levels of vasoactive intestinal peptide(VIP)and somatostatin(SS)decreased in both groups,while the levels of gastrin(GAS),motilin(MTL),and cholecystokinin(CCK)increased com-pared with those before treatment.The VIP and SS levels in the study group were lower than those in the control group,while the GAS,MTL,and CCK levels were higher(P<0.05).After three cy-cles of treatment,the neutrophil-to-lymphocyte ratio(NLR)and platelet-to-lymphocyte ratio(PLR)decreased,and the lymphocyte-to-monocyte ratio(LMR)level increased in both groups compared with those before treatment.The NLR and PLR levels in the study group were lower than those in the control group,while the LMR level was higher(P<0.05).There was no statistically significant difference in the incidence of adverse reactions between the study group and the control group(P>0.05).Conclusion PD-1/PD-L1 inhibitors combined with chemotherapy for AGC can improve short-term efficacy,enhance gastrointestinal function,reduce NLR and PLR levels in peripheral blood,increase LMR levels in peripheral blood,and do not increase adverse reactions.The combi-nation therapy is relatively safe.
8.Mechanism of aprepitant in reversing chemoresistance in colorectal cancer mice through endoplasmic reticulum stress
Shaolan CHEN ; Jun LUO ; Shusheng PENG ; Jing RAN ; Xianhui YOU
Journal of Clinical Medicine in Practice 2025;29(2):69-74
Objective To investigate the molecular mechanism of aprepitant(Apr)reversing 5-Fluorouracil(5-FU)resistance in colorectal cancer(CRC)mouse model through endoplasmic re-ticulum stress(ERS).Methods Thirty mice were selected as experimental animals.Five mice were randomly assigned to control group,and the remaining 25 mice underwent subcutaneous injection in the back to establish the HCT-116/5-FU CRC mouse model.These mice were then divided into the CRC group,5-FU group,Apr group,Apr+5-FU group and Apr+ERS inhibitor Tauroursodeoxychol-ic acid(TUDCA)group,with five mice in each group.Changes in body weight and tumorigenesis in mice were recorded,and their organ indicators were calculated.Western blotting(WB)was used to detect the protein expression levels of protein kinase R-like ER kinase(PERK),eukaryotic initiation factor 2 subunit α(eIF2α),activating transcription factor 4(ATF4)and C/EBP homologous protein(CHOP)in each group.Results At 5,10,15 and 20 d after medication,there were no statistically significant differences in body weight among CRC,5-FU,Apr,Apr+5-FU and Apr+TUDCA groups,neither in time points nor in interactions(P>0.05).Two days after the last administration,there was no significant difference in the indexes of thymus,lung,liver,spleen,heart,kidney and other organs among all groups(P>0.05).Compared with CRC group,the protein expression levels of PERK,P-EIF2α/eIF2α,ATF4 and CHOP in Apr group and Apr+5-FU group were significantly increased,the number of tumors was significantly decreased,the tumor mass was significantly de-creased,and the tumor volume was significantly decreased(P<0.05),and the improvement of Apr+5-FU group was better than that of other groups(P<0.05).Conclusion Apr can enhance chemotherapy sensitivity and reverse chemotherapy resistance in CRC mice,which may be mediated by downstream molecules of ERS pathway.
9.Expert Consensus on the Ethical Requirements for Generative AI-Assisted Academic Writing
You-Quan BU ; Yong-Fu CAO ; Zeng-Yi CHANG ; Hong-Yu CHEN ; Xiao-Wei CHEN ; Yuan-Yuan CHEN ; Zhu-Cheng CHEN ; Rui DENG ; Jie DING ; Zhong-Kai FAN ; Guo-Quan GAO ; Xu GAO ; Lan HU ; Xiao-Qing HU ; Hong-Ti JIA ; Ying KONG ; En-Min LI ; Ling LI ; Yu-Hua LI ; Jun-Rong LIU ; Zhi-Qiang LIU ; Ya-Ping LUO ; Xue-Mei LV ; Yan-Xi PEI ; Xiao-Zhong PENG ; Qi-Qun TANG ; You WAN ; Yong WANG ; Ming-Xu WANG ; Xian WANG ; Guang-Kuan XIE ; Jun XIE ; Xiao-Hua YAN ; Mei YIN ; Zhong-Shan YU ; Chun-Yan ZHOU ; Rui-Fang ZHU
Chinese Journal of Biochemistry and Molecular Biology 2025;41(6):826-832
With the rapid development of generative artificial intelligence(GAI)technologies,their widespread application in academic research and writing is continuously expanding the boundaries of sci-entific inquiry.However,this trend has also raised a series of ethical and regulatory challenges,inclu-ding issues related to authorship,content authenticity,citation accuracy,and accountability.In light of the growing involvement of AI in generating academic content,establishing an open,controllable,and trustworthy ethical governance framework has become a key task for safeguarding research integrity and maintaining trust within the academic community.This expert consensus outlines ethical requirements across key stages of AI-assisted academic writing-including topic selection,data management,citation practices,and authorship attribution.It aims to clarify the boundaries and ethical obligations surrounding AI use in academic writing,ensuring that technological tools enhance efficiency without compromising in-tegrity.The goal is to provide guidance and institutional support for building a responsible and sustainable research ecosystem.
10.Hospitalization expense analysis of pneumonia patients using the CatBoost and LightGBM models
Xiaoping YOU ; Zhiwu ZOU ; Chen YANG ; Chao PENG ; Yan ZHANG
Modern Hospital 2025;25(2):248-251
Objective To predict the hospitalization expense of pneumonia patients using the CatBoost and LightGBM models and explore associated influencing factors,providing a scientific basis for reasonable control of medical expenses and alle-viating the financial burden on society and patients'families.Methods Data from 1407 inpatients with pneumonia admitted to a tertiary hospital between November 1,2021 and January 31,2023 were collected from the hospital information system.The Cat-Boost and LightGBM models were employed to predict the hospitalization expenses of pneumonia patients and analyze the influen-cing factors.Results The full-variable CatBoost model fitted better than the full-variable LightGBM model,with the R-square value of 0.859 and Mean Absolute Percentage Error(MAPE)of 0.352.The full-variable CatBoost model predicted better than the full-variable LightGBM model,with the R-square value of 0.820 and MAPE of 0.363.Notably,the average length of stay was the most important factor affecting the hospitalization expenses of pneumonia patients.Conclusion Compared to the LightGBM model,the CatBoost model indicated more advantages and higher accuracy in predicting hospitalization expenses for pneumonia patients.These accurate predictions of hospitalization expenses can provide decision-making references for hospital administra-tors.Therefore,on the premise of ensuring medical quality,reasonably reducing the length of hospitalization can effectively con-trol the increase in hospitalization expenses.


Result Analysis
Print
Save
E-mail